Similarly, Sang et al. (2021) developed a liver fibrosis prediction model for NAFLD patients from China, Malaysia, and India using nine parameters, including age, BMI, fasting blood glucose, diabetes status, alanine aminotransferase (ALT), γ-glutamyl transferase, triglycerides, and the aspartate transaminase (AST)-to-platelet ratio. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.